Ophthalmology۲۰۲۶نمایه شده در PubMed
César A Briceño, Oluwatobi O Idowu, Jwu Jin Khong, Thomas Kuenzel, Ann Q Tran, Christopher Brittain, Atsushi Azumi, Laura Brockwell, Nima Ghadiri, Mariano Coronel, Thorsten Ruf, Dongmei Li, Mario Salvi, Antonio Manuel Garrido-Hermosilla, Giulio Barteselli, Santiago Ortiz-Perez, of the SatraGO-1 and SatraGO-2 investigators
چکیده
To evaluate the primary efficacy and safety of satralizumab, an anti-interleukin-6 receptor antibody, in patients with thyroid eye disease (TED). SatraGO-1 (NCT05987423) and SatraGO-2 (NCT06106828) are identically designed, 72-week, double-masked, placebo-controlled, multicenter, 2-stage…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.ophtha.2026.08.039